Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached herewith Press Release.07-11-2023
07-11-2023
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached herewith Investor Presentation.07-11-2023
Supriya Lifescience Ltd - 543434 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023
Please find attachment.07-11-2023
Supriya Lifescience Ltd - 543434 - Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Tuesday, November 7, 2023, inter-alia considered and approved the Unaudited Financial Results for the Quarter and half year ended September 30, 2023.07-11-2023
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached herewith Press Release.06-11-2023
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Wednesday, November 8, 2023 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and half year ended September 30, 2023 (Q2 & H1 of FY 2023-24). The invite giving requisite details including the pre-registration link and dial-in details is attached herewith.27-10-2023
Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023
Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2023.27-10-2023
Supriya Lifescience and KIIT collaborate on oral cancer detection kit
Initiative marks portfolio-diversification for the Mumbai-based API-maker24-10-2023
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached herewith Press Release.23-10-2023
Supriya Lifescience Ltd - 543434 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith certificate under Reg 74 (5) of SEBI DP Regulation, 2018.11-10-2023